retatrutide clinical trial stage VisualAbstract: reduces body weight by 17.5% in patients with obesity Eli Lilly infiltrates anti-obesity market

IGF-1 and cardiovascular disease [PMID: 30735831] Laboratory literature summary: IGF-1 and cardiovascular disease

The liver fat content (LFC) was comparable in both groups at baseline (15.67% for the tirzepatide group vs

So not something within the ovary or a lack of the pituitary to make LH or FSH, but a deficit of the hypothalamus to promote LH and FSH and the downstream hormones, testosterone and estrogen

Most side effects are manageable with proper preparation and technique

In oncology, although most meta-analyses reported no significant association between GLP-1 RAs and overall cancer risk, a possible reduced risk of prostate neoplasm was observed in individuals with T2DM

Want to read this story later